How many institutions own CYTH stock?

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own CYTH shares is 28, representing 11.45% of the company's common stock.

Who are the major shareholders selling Cyclo Therapeutics, Inc. stock?

BANK OF AMERICA CORP /DE/, in the last quarter, reduced its stake in CYTH by -82.9% restricting it's holding to 170 shares of worth nearly $100.00. ROYAL BANK OF CANADA also lessened -100% of the CYTH shares from its portfolio, reducing its holding to 0 shares of worth -. JPMORGAN CHASE & CO also shunned CYTH shares holding by -0.52% last quarter which brought its holding to 193 shares worth $114.00.

Investors who are buying CYTH stock?

As per its latest 13F filing, FMR LLC increased its stake in CYTH by 100% in the last quarter. The institutional holder raised its holding to 30 shares having worth more than $18.00. TOWER RESEARCH CAPITAL LLC (TRC) also added 23.89% more shares of CYTH to its portfolio, raising its holding to 6.68 thousand shares of worth $3.94K. also increased its CYTH shares holding by 100% which brought its holding to 11 shares worth $6.00.

CYTH's major insiders: who are they?

The insider with the most stakes in CYTH is ARMISTICE CAPITAL, LLC , 10 percent owner at the company. Additionally, CYTH stock is highly held by 10 percent owner Rafael Holdings, Inc. and Chief Executive Officer FINE N SCOTT among others.

Did an insider recently sell CYTH stock?

Company executives, directors, and other insiders own 48.45% percent of Cyclo Therapeutics, Inc.'s stock. Within the last six months, there have been 0 transaction(s) in which CYTH insiders have sold stock, totaling 0 shares. Insiders that have sold shares include ARMISTICE CAPITAL, LLC.

Which insider recently purchased CYTH stock?

There have been 0 transaction(s) during the past 6-months in which Cyclo Therapeutics, Inc. insiders have bought stock, totalling 0 shares

How much of CYTH does insiders own?

Around 0 Cyclo Therapeutics, Inc. shares are held by insiders, which represents about 48.45% of CYTH stock.

Who is the insider with the largest stake?

CYTH 10 percent owner, ARMISTICE CAPITAL, LLC holds the largest portfolio of the company's shares. CYTH shares owned by ARMISTICE total nearly 15.8 million.

Which institution holds the most shares in CYTH?

BANK OF AMERICA CORP /DE/ is the largest institutional owner in CYTH which holds 170 shares worth $100.00 or 0% of the total CYTH shares outstanding followed by FMR LLC with ownership of 30 shares representing 0% of the CYTH ownership. ROYAL BANK OF CANADA is the third largest stakeholder with 0 shares or 0% of the ownership worth more than -.

Is Cyclo Therapeutics, Inc. stock optionable?

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the CYTH is concerned, it is a stock which is not optionable.

Is there a short position on CYTH's shares?

Number of CYTH shares short is 434.12K. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

About how many outstanding CYTH shares are there?

As of today, 32.74M shares of CYTH are outstanding.

Is there many float in CYTH stock?

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, CYTH has 11.51M shares in float.

CYTH short ratio: what is it?

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for CYTH is 5.58.

Cyclo Therapeutics (CYTH) insider trading activity: Get Latest News Today

Stock Outstanding Shares

Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.

ShortableNo

OptionableNo

Short Percent Of Outstanding Shares1.33

Short Percent Of Float1.51

Shares Outstanding32.74M

Shares Float11.51M

Shares Short434.12K

Short Ratio5.58

1.51%

Short % of Float

1.33%

Short % of Shares Outstanding

Market Insider

Investors cannot turn a blind eye to insiders as well as institutional ownership. They need to follow insider trades to determine the direction the stock is likely to take.

Major Holders Summary

48.45% Percentage of Shares held by All Insiders

11.45% Percentage of Shares held by All Institutions

22.21% Percentage of Float held by Institutions

Number of Institutions Holding Shares

Institutional Ownership

About 11.45% of CYTH shares are held by financial institutions. BANK OF AMERICA CORP /DE/ is the top corporate investor, holding 170 shares valued at $100.00. A 0% stake in Cyclo Therapeutics, Inc. is owned by the company. FMR LLC owns 30 shares valued at $18.00, which translates its holding of 0% of the stake in the company.

Date	Holder	% Stake	Shares Held	Total Value ($)	Shares	% Change in Portfolio
Dec 31, 2024	BANK OF AMERICA CORP /DE/	0%	170	100	-824	-82.90%
Dec 31, 2024	FMR LLC	0%	30	18	30	+100.00%
Dec 31, 2024	ROYAL BANK OF CANADA	0%	0	-	-821	-100.00%
Dec 31, 2024	TOWER RESEARCH CAPITAL LLC (TRC)	0.02%	6.68K	3.94K	1.29K	+23.89%
Dec 31, 2024	JPMORGAN CHASE & CO	0%	193	114	-1	-0.52%
Dec 31, 2024		0%	11	6	11	+100.00%
Dec 31, 2024	TWO SIGMA SECURITIES, LLC	0.15%	42.54K	25.1K	42.54K	+100.00%
Dec 31, 2024	EPIQ CAPITAL GROUP, LLC	2.4%	689.45K	406.77K	-49.98K	-6.76%
Dec 31, 2024	BNP PARIBAS ARBITRAGE, SNC	0%	1	1	1	+100.00%
Dec 31, 2024	SBI SECURITIES CO., LTD.	0%	11	6	11	+100.00%
Dec 31, 2024	PRINCETON GLOBAL ASSET MANAGEMENT LLC	0%	0	-	-3.47K	-100.00%
Dec 31, 2024	MORGAN STANLEY	0%	1.03K	608	0	0
Dec 31, 2024	GEODE CAPITAL MANAGEMENT, LLC	0.53%	152.33K	89.91K	0	0
Dec 31, 2024	BLACKROCK, INC.	0.29%	83.82K	49.46K	301	+0.36%
Dec 31, 2024	VANGUARD GROUP INC	2.08%	598.69K	353.23K	0	0
Dec 31, 2024	FOUNDERS FUND V MANAGEMENT, LLC	1.67%	480.71K	283.62K	0	0
Dec 31, 2024	STATE STREET CORP	0.14%	39.53K	23.32K	0	0
Dec 31, 2024	NORTHERN TRUST CORP	0.08%	21.74K	12.82K	14	+0.06%
Dec 31, 2024	WEALTH ENHANCEMENT ADVISORY SERVICES, LLC	0.06%	18.29K	10.79K	-5.12K	-21.86%
Dec 31, 2024	UBS GROUP AG	0.04%	11.99K	7.07K	-471	-3.78%
Dec 31, 2024	WELLS FARGO & COMPANY/MN	0.02%	4.39K	2.59K	0	0
Dec 31, 2024	STEWARD PARTNERS INVESTMENT ADVISORY, LLC	0%	90	53	0	0

Insiders

Among the CYTH insiders holding of 48.45% of the stake in company, ARMISTICE CAPITAL, LLC, 10 percent owner, holds the largest shares of 15.8M. RAFAEL HOLDINGS, INC., 10 percent owner, is the second largest CYTH insider with ownership of 2.77M shares. FINE N SCOTT, Chief Executive Officer, stands third with possession of 329.34K shares of that stake.

Insiders	Designation	Shares Held
ARMISTICE CAPITAL, LLC	10 percent owner	15.8M
RAFAEL HOLDINGS, INC.	10 percent owner	2.77M
FINE N SCOTT	Chief Executive Officer	329.34K
OSTRONIC FRANCIS PATRICK	director	65.87K
SIEGER MARKUS	director	65.87K
TATE JEFFREY	Chief Operating Officer	32.94K
SHANAHAN WILLIAM S	director	20K
HRYNKOW SHARON HEMOND	Chief Scientific Officer	19.35K
FINE JOSHUA M	Chief Financial Officer	16.9K
TOIG RANDALL M.	director	10K

Buying/Selling by Insiders

Date	Insider	Type	Cost	Shares	Value ($)	Shares Total
Oct 20, 2023	OSTRONIC FRANCIS PATRICK	PURCHASE	0.95	65.87K	62.58K	65.87K
Oct 20, 2023	RAFAEL HOLDINGS, INC.	PURCHASE	0.95	2.77M	2.63M	2.77M
Oct 20, 2023	FINE N SCOTT	PURCHASE	0.95	329.34K	312.87K	329.34K
Oct 20, 2023	TATE JEFFREY	PURCHASE	0.95	32.94K	31.29K	32.94K
Oct 20, 2023	SIEGER MARKUS	PURCHASE	0.95	65.87K	62.58K	65.87K
Aug 01, 2023	RAFAEL HOLDINGS, INC.	PURCHASE	1.25	4M	5M	4M
Apr 20, 2023	TATE JEFFREY	PURCHASE	0.71	29.94K	21.26K	29.94K
Apr 20, 2023	OSTRONIC FRANCIS PATRICK	PURCHASE	0.71	59.88K	42.52K	59.88K
Apr 20, 2023	SIEGER MARKUS	PURCHASE	0.71	59.88K	42.52K	59.88K
Apr 20, 2023	FINE N SCOTT	PURCHASE	0.71	299.4K	212.58K	299.4K
Sep 21, 2022	OSTRONIC FRANCIS PATRICK	PURCHASE	1.76	5K	8.8K	150.69K
May 20, 2022	OSTRONIC FRANCIS PATRICK	PURCHASE	2.00	12	24	133.54K
May 16, 2022	TATE JEFFREY	PURCHASE	2.12	3K	6.35K	32.16K
Apr 29, 2022	TATE JEFFREY	PURCHASE	2.70	300	810	28.1K
Apr 28, 2022	TATE JEFFREY	PURCHASE	2.50	635	1.59K	27.8K
Mar 29, 2022	SIEGER MARKUS	PURCHASE	2.73	10K	27.3K	81.69K
Feb 07, 2022	FINE N SCOTT	PURCHASE	3.58	10.33K	37K	145K
Jan 24, 2022	OSTRONIC FRANCIS PATRICK	PURCHASE	3.75	2K	7.5K	113.21K
Jan 19, 2022	OSTRONIC FRANCIS PATRICK	PURCHASE	4.00	1.13K	4.53K	111.21K
Jan 19, 2022	FINE N SCOTT	PURCHASE	3.89	5K	19.45K	134.67K
Jan 14, 2022	OSTRONIC FRANCIS PATRICK	PURCHASE	4.00	2.14K	8.55K	108.35K
Dec 15, 2021	OSTRONIC FRANCIS PATRICK	PURCHASE	3.90	3K	11.7K	106.21K
Dec 15, 2021	FINE N SCOTT	PURCHASE	3.89	5K	19.45K	129.67K
Dec 10, 2021	OSTRONIC FRANCIS PATRICK	PURCHASE	4.40	5K	22K	103.21K
Dec 03, 2021	OSTRONIC FRANCIS PATRICK	PURCHASE	4.75	864	4.1K	98.21K
Dec 02, 2021	HRYNKOW SHARON HEMOND	PURCHASE	4.98	1K	4.98K	19.35K
Dec 02, 2021	FINE N SCOTT	PURCHASE	4.93	5K	24.65K	124.67K
Dec 02, 2021	OSTRONIC FRANCIS PATRICK	PURCHASE	4.75	4.14K	19.65K	97.35K
Dec 01, 2021	OSTRONIC FRANCIS PATRICK	PURCHASE	5.00	5K	25K	93.21K
Nov 19, 2021	OSTRONIC FRANCIS PATRICK	PURCHASE	5.22	652	3.4K	78.21K
Nov 19, 2021	FINE N SCOTT	PURCHASE	5.25	5K	26.25K	119.67K
Oct 29, 2021	OSTRONIC FRANCIS PATRICK	PURCHASE	5.90	1K	5.9K	77.56K
Sep 15, 2021	FINE N SCOTT	PURCHASE	6.35	5K	31.75K	114.67K
Jun 18, 2021	SIEGER MARKUS	PURCHASE	5.00	7.5K	37.5K	37.5K
May 21, 2021	OSTRONIC FRANCIS PATRICK	PURCHASE	5.00	100	500	100
May 21, 2021	SIEGER MARKUS	PURCHASE	5.00	3.48K	17.41K	30K
May 20, 2021	SIEGER MARKUS	PURCHASE	5.00	2.31K	11.56K	26.52K
May 19, 2021	SIEGER MARKUS	PURCHASE	5.00	9.21K	46.03K	24.21K
Apr 16, 2021	OSTRONIC FRANCIS PATRICK	PURCHASE	6.75	5K	33.75K	71.56K
Apr 12, 2021	OSTRONIC FRANCIS PATRICK	PURCHASE	7.00	5K	35K	66.56K
Mar 29, 2021	TATE JEFFREY	PURCHASE	7.50	2K	15K	27.16K
Mar 29, 2021	FINE JOSHUA M	PURCHASE	7.40	50	370	16.9K
Mar 29, 2021	SIEGER MARKUS	PURCHASE	8.10	10K	81K	67.61K
Mar 29, 2021	OSTRONIC FRANCIS PATRICK	PURCHASE	7.40	1K	7.4K	59.56K
Mar 29, 2021	HRYNKOW SHARON HEMOND	PURCHASE	7.46	1K	7.46K	18.35K
Jan 26, 2021	SIEGER MARKUS	PURCHASE	6.60	2.2K	14.53K	57.61K
Jan 25, 2021	SIEGER MARKUS	PURCHASE	6.20	3K	18.59K	50.61K
Dec 17, 2020	OSTRONIC FRANCIS PATRICK	PURCHASE	4.55	5K	22.75K	33.56K
Dec 11, 2020	SIEGER MARKUS	PURCHASE	5.00	15K	75K	15K
Dec 11, 2020	TATE JEFFREY	PURCHASE	5.00	5K	25K	5K
Dec 11, 2020	FINE N SCOTT	PURCHASE	5.00	20K	100K	20K
Dec 11, 2020	HRYNKOW SHARON HEMOND	PURCHASE	5.00	1K	5K	1K
Dec 11, 2020	SHANAHAN WILLIAM S	PURCHASE	5.00	20K	100K	20K
Dec 11, 2020	TOIG RANDALL M.	PURCHASE	5.00	10K	50K	10K
Nov 25, 2020	FINE JOSHUA M	PURCHASE	0.07	15K	1.13K	685K
Nov 23, 2020	FINE JOSHUA M	PURCHASE	0.08	10K	799	670K
Sep 30, 2020	ARMISTICE CAPITAL, LLC	SALE	0.00	0	-	15.8M
Sep 29, 2020	ARMISTICE CAPITAL, LLC	SALE	0.00	0	-	15.8M
Sep 28, 2020	ARMISTICE CAPITAL, LLC	SALE	0.00	0	-	15.81M
Sep 24, 2020	ARMISTICE CAPITAL, LLC	SALE	0.00	0	-	15.81M
Sep 23, 2020	ARMISTICE CAPITAL, LLC	SALE	0.00	0	-	15.85M
Sep 22, 2020	ARMISTICE CAPITAL, LLC	SALE	0.00	0	-	15.9M
Sep 21, 2020	ARMISTICE CAPITAL, LLC	SALE	0.00	0	-	15.92M
Sep 16, 2020	ARMISTICE CAPITAL, LLC	SALE	0.00	0	-	16.02M
Sep 15, 2020	ARMISTICE CAPITAL, LLC	SALE	0.00	0	-	16.14M
Sep 14, 2020	ARMISTICE CAPITAL, LLC	SALE	0.00	0	-	16.22M
Sep 11, 2020	ARMISTICE CAPITAL, LLC	SALE	0.17	170K	28.9K	16.35M
Sep 10, 2020	ARMISTICE CAPITAL, LLC	SALE	0.17	282.5K	48.03K	16.52M
Sep 09, 2020	ARMISTICE CAPITAL, LLC	SALE	0.00	0	-	16.81M

CYTH Stock Ownership Breakdown